Tag: Alzheimer’s Disease

Eisai, Biogen secure Leqembi FDA accelerated approval for Alzheimer’s disease

Raghuram Kadari- January 9, 2023

Eisai and Biogen have secured the approval of the US Food and Drug Administration (FDA) for their jointly developed Leqembi (lecanemab-irmb) under the accelerated approval ... Read More

Suven Life Sciences begins Masupirdine phase 3 clinical trial in dementia patients

businessnewstoday- November 19, 2022

Suven Life Sciences has started a global phase 3 clinical trial of Masupirdine in dementia of the Alzheimer's type by randomizing the first patient. According ... Read More

Suven Life Sciences to launch phase 3 clinical trial for Masupirdine

pallavi123- August 16, 2021

Suven Life Sciences is set to launch a phase 3 clinical trial for its 5-HT6 antagonist SUVN-502 (Masupirdine) for the treatment of agitation and aggression ... Read More

PostEra, NeuroLucent to partner on identifying small-molecule therapeutics for Alzheimer’s

pharmanewsdaily- November 26, 2020

PostEra, a UK-based biotech company, has entered into a collaboration with NeuroLucent, a US company focused on developing drugs for the treatment of Alzheimer's disease ... Read More

PostEra, NeuroLucent to partner on identifying small-molecule therapeutics for Alzheimer’s

pharmanewsdaily- November 26, 2020

PostEra, a UK-based biotech company, has entered into a collaboration with NeuroLucent, a US company focused on developing drugs for the treatment of Alzheimer’s disease ... Read More

UCB signs $2bn worth deal with Roche for AD drug candidate UCB0107

pharmanewsdaily- July 29, 2020

Belgian pharma company UCB has signed a global exclusive license deal worth up to $2 billion for its Alzheimer's Disease drug candidate (AD drug candidate) ... Read More

NeuroBo, Gemphire merger wrapped up to form neurodegenerative disease company

pharmanewsdaily- January 13, 2020

NeuroBo Pharmaceuticals,  a Boston-based clinical-stage pharma company, has wrapped up its previously announced merger with Gemphire Therapeutics, a Michigan-based clinical-stage biopharma company focused on developing ... Read More

Effective drug for Alzheimer’s treatment will be available soon

pharmanewsdaily- March 21, 2018

As per the latest reports from the experts, an effective drug to treat Alzeihmer’s disease will be available soon and also a vaccine to prevent ... Read More